Assembly Biosciences Inc

XNAS:ASMB 4:00:00 PM EDT

32.35

-0.23 (-0.71%)

5:40:54 PM EDT: $32.35 0.00 (0.00%)

Market Cap (Intraday)	511.66M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$7.42 Million
Adjusted EPS	-$0.86

See more estimates

10-Day MA	$34.25
50-Day MA	$32.64
200-Day MA	$20.91

See more pivots

Assembly Biosciences Inc Stock, XNAS:ASMB

Two Tower Place, 7th floor, South San Francisco, California 94080

United States of America

Phone: +1.833.509.4583

Number of Employees: 65

http://www.assemblybio.com

Description

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.